Skip to search formSkip to main contentSkip to account menu

SAR 020106

Known as: SAR-020106, SAR020106 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

IsoquinolinesPyrazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
P05.02 The Chk1 inhibitor SAR-020106 abrogates the irradiation-induced G2 arrest and enhances the effect of irradiation on the clonogenic survival of human p53-mutant glioblastoma cells
2013
2013
Optimisation de la radiovirothérapie en associant un traitement radio-isotopique vectorisé par un virus de la rougeole oncolytique, une radiothérapie externe et une inhibition de checkpoint kinase-1
La radiovirotherapie est definie comme etant l'utilisation de virus infectant les cellules cancereuses pour guider un traitement… 
2010
2010
Abstract 3518: Preclinical pharmacology of the novel, potent & selective CHK1 inhibitor SAR-020106
Genotoxic antitumor agents continue to be the mainstay of current cancer chemotherapy. These drugs cause DNA damage and activate… 
2009
2009
Molecular Cancer Therapeutics The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK 1 Inhibitor SAR-020106
Authors' Therapeuti Sutton, Su Kingdom Note: Sup Cancer The Correspon Cancer Th Laboratorie Kingdom. P Mike.Walto 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)